Niagen Bioscience's total assets for Q2 2025 were $91.53M, an increase of 12.53% from the previous quarter. NAGE total liabilities were $27.33M for the fiscal quarter, a 5.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.